Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2)

NCT02768545 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Ezetimibe

Sponsor

Pontificia Universidad Catolica de Chile